| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
-Mediated Induction of Human Coagulation Factor XII Gene1
Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute (A.F., F.M., M.N., S.M., S.N., A.S., A.P.); the Institute of Experimental Medicine, National Research Council/Second Chair of Endocrinology, University of Rome La Sapienza (A.F., F.M., S.M., M.A.); and the Institute of Medical Pathology, Catholic University (A.P.), Rome, Italy
Address all correspondence and requests for reprints to: Alfredo Pontecorvi, M.D., Catholic University and Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Via delle Messi dOro 156, 00158 Rome, Italy.
Factor XII (FXII) is a liver-specific zymogen involved in the
regulation of hemostasis, particularly in the activation of
fibrinolysis. Transcription of the FXII gene is stimulated by estrogens
through specific interaction of the estrogen receptor
(ER
) with
an estrogen response element present on FXII promoter. Interestingly,
the magnitude of ER
induction in liver HepG2 cells is much lower
than in NIH3T3 fibroblasts, suggesting that cell-specific factors may
modulate ER
-dependent trans-activation. Comparative
footprinting analysis of FXII promoter (from nucleotides -181 to +49)
in liver vs. non-liver cell environments allowed
identification of four deoxyribonuclease I-protected sites only in the
presence of HepG2 nuclear extracts. Computerized homology search
identified sites III and IV as consensus binding sequences for the
liver-enriched transcription factor hepatocyte nuclear factor-4
(HNF-4), formerly an orphan receptor belonging to the superfamily of
steroid/thyroid hormone nuclear receptors. In transient transfection
assays in NIH3T3 cells, HNF-4 significantly inhibited (70%) estrogen
induction of FXII promoter while not affecting basal promoter activity.
Conversely, HNF-4 did not inhibit estrogen inducibility of FXII
promoter in HepG2 cells due to the high endogenous levels of HNF-4
protein. In gel shift assays, HNF-4, either present in HepG2 nuclear
extracts or generated by in vitro
transcription/translation, specifically bound FXII promoter. This
interaction is strictly required in eliciting the antagonistic effect
because in NIH3T3 cells, selective mutations of sites III and IV
abrogated HNF-4 inhibitory properties. In the liver-specific
environment, the same mutant construct exhibited higher
estrogen-dependent inducibility compared with native promoter. Rescue
of estrogen responsiveness was also achieved using a dominant negative
HNF-4, which counteracted endogenous HNF-4 activity. In conclusion, our
findings address a direct role for HNF-4 in modulating
estrogen-dependent transcription of the FXII gene promoter.
This article has been cited by other articles:
![]() |
M. Marino, F. Acconcia, and A. Trentalance Biphasic Estradiol-induced AKT Phosphorylation Is Modulated by PTEN via MAP Kinase in HepG2 Cells Mol. Biol. Cell, June 1, 2003; 14(6): 2583 - 2591. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marino, F. Acconcia, F. Bresciani, A. Weisz, and A. Trentalance Distinct Nongenomic Signal Transduction Pathways Controlled by 17beta -Estradiol Regulate DNA Synthesis and Cyclin D1 Gene Transcription in HepG2 Cells Mol. Biol. Cell, October 1, 2002; 13(10): 3720 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Di Bitondo, A. J. Hall, I. R. Peake, L. Iacoviello, and P. R. Winship Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region Hum. Mol. Genet., April 1, 2002; 11(7): 723 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Guo, C. Q. Cai, and P. C. Kuo Hepatocyte Nuclear Factor-4alpha Mediates Redox Sensitivity of Inducible Nitric-oxide Synthase Gene Transcription J. Biol. Chem., February 8, 2002; 277(7): 5054 - 5060. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Farsetti, M. Narducci, F. Moretti, S. Nanni, R. Mantovani, A. Sacchi, and A. Pontecorvi Inhibition of ER{alpha}-Mediated Trans-Activation of Human Coagulation Factor XII Gene by Heteromeric Transcription Factor NF-Y Endocrinology, August 1, 2001; 142(8): 3380 - 3388. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |